Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, James I. Mullins, Chivonne Moodley et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIVNonhlanhla N. Mkhize, Sinead Delany‐Moretlwe, Bo Zhang et al.|Nature Communications|2025Cited by 1
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention TrialsCarolyn Williamson, James I. Mullins, Raabya Rossenkhan et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic SettingTaraz Samandari, James G. Kublin, Millicent Achola et al.|medRxiv|2025Cited by 0
<i>Plasmodium falciparum</i> Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected AdultsTaraz Samandari, James G. Kublin, Millicent Achola et al.|The Journal of Infectious Diseases|2025Cited by 0